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CASE OF THE MONTH      Jaya Buddineni, MD 
A 35 year old Hispanic male, with no significant past medical history, presented to the ER complaining of 
fever, cough and myalgias.  The patient had gone to another ER 8 days prior to this presentation with less 
severe complaints and was diagnosed with a left lingular pneumonia; he was sent home on a course of Bi-
axin.  After initially improving, he developed left sided chest pain, productive cough, hemoptysis, fever, nau-
sea and right upper quadrant abdominal pain.  The patient lives with three healthy room-mates and denied a 
history of recent travel, sick contacts or exposure to animals.  He works in a restaurant and reported a history 
of salmonella infection 3 years ago, for which he received antibiotics.  He denied any history of tobacco, alco-
hol or illicit drug use. 
On arrival, the patient was  afebrile, tachycardic, and normotensive with a RR of 18/min and saturating 96% 
on RA.  He appeared to be in mild distress and lung exam revealed diffuse, coarse rhonchi, greater on the left 
side.  Abdominal exam revealed RUQ tenderness with normal bowel sounds and no organomegaly.  The re-
mainder of his physical exam was within normal limits.  
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Lab data revealed a low WBC, severe normocytic anemia and a platelet count of 43,000.  He had mild hypo-
natremia, hypokalemia, hypochloridemia and normal renal function.  Hepatic labs revealed a marked hypo-
albuminemia, normal total protein, hyperbilirubinemia, elevated transaminases and a high alkaline phos-
phatase.  A peripheral blood smear demonstrated numerous schistocytes with enlarged platelets; further 
workup revealed an elevated reticulocyte count, high LDH and decreased haptoglobin.  A CXR showed pro-
gression of the left lingular infiltrate and an associated effusion.  A hepatitis profile and legionella antigen 
were negative; an ultrasound of the RUQ was also WNL. 
The patient was admitted to the IM service and, after appropriate cultures were obtained, he was started on 
IV Vancomycin, Zosyn and doxycycline.  A CT of the chest demonstated lingular and LLL consolidation, a 
left pleural effusion with loculations, a mild right pleural effusion and splenomegaly.  CT Surgery was con-
sulted and the patient underwent a VATS procedure for drainage and decortication; the pleural fluid was 
exudative, consistent with a parapneumonic effusion, but the gram stain and culture were negative; results of 
serologic testing for IgM and IgG are still pending.  All cultures remained negative, lab abnormalities cor-
rected, the patient’s clinical status improved and he is currently undergoing pulmonary rehabilitation. 
DISCUSSION:  This is a case of partially-treated, community acquired pneumonia (CAP), presenting with 
severe complications of parapneumonic effusion, empyema, hemolytic anemia and pancytopenia.  Common 
pathogens of CAP that may present with hemolysis include mycoplasma [3] and, less commonly, strep pneu-
monia with hemolytic-uremic syndrome.  Pathogens that cause atypical pneumonia tend to produce more 
extra pulmonary manifestations than occurs in typical pneumonia.  Atypical pneumonia can pose a diagnos-
tic challenge for clinicians since there are no diagnostic tests for reliable and early detection of atypical organ-
isms [2] and since partial treatment of CAP with antibiotics may mask important clinical signs.  Serologic 
tests, including ELISA, indirect fluorescent antibody assay and particle agglutination to detect IgM and IgG, 
are increasingly used to diagnose atypical pneumonia.  Although these tests may aid in the identification of 
the pathogen, delayed results and economic burden are significant barriers and they seldom help in early 
management decisions, including empiric antibiotic coverage.  The 2007 IDSA/ATS consensus guidelines rec-
ommend diagnostic testing for a specific organism only when empiric antibiotic therapy fails to result in 
clinical improvement.  Diagnostic testing for outpatient management of CAP is considered optional [1]. 
REFERENCES: 
1. Mandell, LA et al., Infectious Diseases Society of America/American Thoracic Society consensus guide-
lines on the management of community acquired pneumonia in adults, Clin Infect Dis 2007; 44 Suppl  
2:S27 
2. Lee, Kathryn A & Edward D Chan, Chapter 37, Viral & Atypical Pneumonia (Chapter), Hanley ME, 
Welsh, http://www.accessmedicine.com/content.aspx?aID=578283 
3. Herbert, BT et al., Hemolytic anemia associated with severe Mycoplasma pneumoniae pneumonia, NY 
State J Med 1978 Dec; 78:2231-2232 
  
 
 
           
Page 6  
               
